Cardiac Biotech Solutions Inc. (CBSC)
OTCMKTS · Delayed Price · Currency is USD
0.0560
0.00 (0.00%)
Feb 13, 2026, 9:30 AM EST
Cardiac Biotech Solutions Revenue
Cardiac Biotech Solutions had revenue of $14.68K in the quarter ending March 31, 2018. This brings the company's revenue in the last twelve months to $50.37K. In the fiscal year ending March 31, 2018, Cardiac Biotech Solutions had annual revenue of $36.61K with 11.11% growth.
Revenue (ttm)
50.37K
Revenue Growth
+11.11%
P/S Ratio
183.60
Revenue / Employee
10.07K
Employees
7
Market Cap
9.25M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2018 | 36.61K | 3.66K | 11.11% |
| Mar 31, 2017 | 32.95K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionCardiac Biotech Solutions News
- 5 months ago - Top 2 Real Estate Stocks You May Want To Dump This Month - Benzinga
- 10 months ago - CB Scientific, Inc. (CBSC) Announces Corporate Name Change to Cardiac Biotech Solutions, Inc. - Accesswire
- 1 year ago - CB Scientific Inc. (CBSC) Formally Launches Next Generation MyCardia AT Cardiac Monitor - Accesswire
- 1 year ago - CB Scientific, Inc. Appoints Trip Thomas as Chief Financial Officer - Accesswire
- 1 year ago - CB Scientific, Inc. Announces Voluntary Delisting from OTCQB Venture Market - Accesswire
- 2 years ago - CB Scientific, Inc. Concludes its Annual Meeting of Stockholders - Accesswire
- 2 years ago - CB Scientific, Inc. 2023 Year in Review - Accesswire
- 3 years ago - CB Scientific, Inc. Announces Exclusive Canadian Distribution Agreement - Accesswire